Daily digest · Wed · 1 Jul 2026

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.

🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic

Hematologic Malignancies

PMID-42379235 · A Phase Ib/II study of ceralasertib, a selective inhibitor of ATR, in patients w... · 9/10 · First clinical data for ATR inhibitor class in R/R MDS/CMML; high unmet need population; published in Blood Advances by PMID-42374628 · Quizartinib in Combination With FLAG-IDA for Relapsed or Refractory Acute Myeloi... · 8/10 · Phase I-II data for a clinically approved FLT3 inhibitor in a novel combination salvage regimen; PETHEMA multicenter; pu

Early Cancer Detection

PMID-42376201 · Accuracy of colposcopy to triage HPV-positive women in cervical cancer screening... · 8/10 · High-impact Lancet-group journal; directly relevant to global cervical cancer prevention; provides actionable accuracy d PMID-42377115 · High-Sensitivity ctDNA Analysis Uncovers Relevant Signals Missed by NGS in Pancr... · 8/10 · Pancreatic cancer has among the highest mortality and fewest diagnostic tools; published in Clinical Cancer Research (AA

AI/ML Diagnostics: No high-priority finds today (best candidate scored 6/10)

Precision Oncology & Genomics: No high-priority finds today (best candidate scored 5/10)

Novel Therapeutics

PMID-42379164 · Lactate binds and inhibits the innate immune sensor STING to promote tumor immun... · 8/10 · Top-tier Immunity publication; identifies novel direct lactate-STING binding mechanism not previously described; major t

Cardiovascular-Metabolic

PMID-42377960 · Sodium-Glucose Cotransporter 2 Inhibitors and Dementia Risk in Patients With Psy... · 9/10 · Novel dementia-prevention signal for SGLT2i in psychiatric patients; JAMA Network Open; large cohort with active compara

Aging & Longevity: No high-priority finds today (best candidate scored 6/10)

Rare Diseases: No high-priority finds today (best candidate scored 7/10)

🟢⚪ STANDARD (5-7) — Top by Topic

Hematologic Malignancies

PMID-42376206 · Ixazomib with chemotherapy for childhood relapsed acute lymphoblastic ... · 7/10 · Drug Development PMID-42374527 · Focal adhesion kinase FAK interplays with ROR1 in the aggressiveness o... · 6/10 · Drug Development PMID-42376773 · Real-world comparative effectiveness of first-line BTK inhibitors in c... · 6/10 · Treatment Innovation PMID-42379984 · Treating large B-cell lymphoma: Current strategies and unmet needs acr... · 6/10 · Treatment Innovation

Early Cancer Detection

PMID-42380047 · HPV Serology and Circulating Viral DNA for Detection, Genotyping, and ... · 7/10 · Early Detection PMID-42374961 · Clinical utility and advances of liquid biopsy in hypopharyngeal carci... · 6/10 · Diagnostics

AI/ML Diagnostics

PMID-42375537 · Machine learning algorithms develop a tumor-educated platelets-related... · 6/10 · Diagnostics PMID-42377542 · Deep learning and machine learning in image-based hepatocellular carci... · 6/10 · Diagnostics PMID-42376625 · Artificial intelligence-driven multimodal fusion for precision diagnos... · 5/10 · Diagnostics PMID-42379462 · Artificial intelligence in diagnostic software: validation, safety, an... · 5/10 · Diagnostics

Precision Oncology & Genomics

PMID-42375141 · Recent advances in HER2-targeted inhibitors for cancer therapy.... · 5/10 · Drug Development PMID-42376597 · Mutation detection in women diagnosed with endometrial cancer: a next-... · 5/10 · Genomics/Precision Medicine PMID-42376987 · Development and Validation of the Steatotic Liver Disease Lab Data Ind... · 5/10 · Diagnostics

Novel Therapeutics

PMID-42375393 · Development of chimeric antigen receptors targeting the γδ T cell rece... · 7/10 · Drug Development PMID-42380095 · Advances and prospects in cell therapy for cancer: explorations from T... · 7/10 · Treatment Innovation PMID-42376655 · Efficacy, long-term survival and safety of different PD-1 inhibitors p... · 6/10 · Treatment Innovation PMID-42377661 · Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Patien... · 6/10 · Treatment Innovation PMID-42377985 · Eliminating PD-L1 on Dendritic Cell Extracellular Vesicles for Immunot... · 6/10 · Drug Development

Cardiovascular-Metabolic

PMID-42376130 · Effect of glucagon-like peptide-1 receptor agonists on major adverse c... · 7/10 · Treatment Innovation PMID-42375334 · Intensive blood pressure control in type 2 diabetes: a meta-analysis o... · 6/10 · Prevention PMID-42376039 · Effects of cardiac rehabilitation on atrial fibrillation recurrence, m... · 6/10 · Treatment Innovation PMID-42380081 · Glucagon-Like Peptide-1 Receptor Agonists in Cocaine Use Disorder: Cli... · 6/10 · Treatment Innovation PMID-42374733 · Clonal Hematopoiesis and Type 2 Diabetes: A Narrative Review.... · 5/10 · Other

Aging & Longevity

PMID-42375109 · Frailty and Cognitive Impairment in Chronic Kidney Disease: A Systemat... · 6/10 · Diagnostics PMID-42378689 · Care Robots as Emerging Health Technologies: Systematic Review and Met... · 6/10 · Public Health

Rare Diseases

PMID-42376650 · CFTR gene delivery to human airway epithelia using parainfluenza virus... · 7/10 · Drug Development PMID-42377466 · Peroxisomal catalase and plasmalogen biosynthesis protect from oxidati... · 7/10 · Drug Development PMID-42379330 · A novel JAK1 mutation identified in a patient with severe atopic derma... · 7/10 · Genomics/Precision Medicine PMID-42379944 · Precision gene editing: From proof-of-concept to curative therapies.... · 7/10 · Drug Development PMID-42375390 · Collagen secretion and maturation in osteogenesis imperfecta: Systemat... · 6/10 · Drug Development

💡 UNSOLICITED FINDS

None today — all high-signal results matched active watchlist topics.

📊 TODAY'S BREAKDOWN

By research category:

Drug Development: 14
Treatment Innovation: 9
Diagnostics: 8
Early Detection: 3
Genomics/Precision Medicine: 2
Prevention: 1
Public Health: 1
Other: 1

By evidence maturity:

Validated: 28
Exploratory: 11

By watchlist topic (reviewed / kept / highest score):

Hematologic Malignancies: 15 reviewed / 6 kept / best score 9
CBC & Hematology ML: 1 reviewed / 0 kept / best score 0
Early Cancer Detection: 15 reviewed / 4 kept / best score 8
AI/ML Diagnostics: 15 reviewed / 4 kept / best score 6
Precision Oncology & Genomics: 15 reviewed / 3 kept / best score 5
Novel Therapeutics: 15 reviewed / 6 kept / best score 8
Cardiovascular-Metabolic: 15 reviewed / 6 kept / best score 9
Aging & Longevity: 15 reviewed / 2 kept / best score 6
Rare Diseases: 15 reviewed / 8 kept / best score 7
Sentinel (Broad Scan): 10 reviewed / 0 kept / best score 0

By source type: peer_reviewed 39 | preprint 0

Topics with zero 8+ articles: CBC & Hematology ML, AI/ML Diagnostics, Precision Oncology & Genomics, Aging & Longevity, Rare Diseases, Sentinel

🔧 RUN NOTES

T2 CBC+ML: 1 result in window; false positive (pharmacokinetics, PMID 42379090); 0 true CBC/ML articles today.
Sentinel scan: 1363 total hits; top 10 reviewed; no new HIGH-priority articles outside watchlist topics.
EClinicalMedicine article 42376201 elevated to HIGH: Lancet-group journal, global cervical cancer screening relevance.
Attempt 2 of 3: corrected schema enum violations (species_model, evidence_maturity, access_level) and score_breakdown axis sums.